HPV-associated oropharynx squamous cell carcinoma (OPSCC) is now one of the most common cancers faced by the Otolaryngology community. Treatment strategies for these patients continue to evolve rapidly because of new technologies including proton therapy, novel systemic therapies including immunotherapy and transoral robotic surgery (TORS). Current treatment approaches vary widely among institutions and national consensus guidelines remain vague. This expert lecture series will review the current best evidence to guide management decisions relevant to general otolaryngologists and head and neck specialists alike with a focus on the role of TORS in a multidisciplinary setting.
- Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
- Activity Link: https://academyu.entnet.org/diweb/catalog/item?id=10926327
- Start Date: 2022-10-12 05:00:00
- End Date: 2022-10-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Head & Neck
Subscribe
Login
0 Comments
Oldest